IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

MARTIGNONI, EMILIA SILVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.128
EU - Europa 3.659
AS - Asia 1.842
SA - Sud America 170
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 7
Totale 12.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.048
IT - Italia 1.789
SG - Singapore 674
UA - Ucraina 618
SE - Svezia 288
VN - Vietnam 284
CN - Cina 268
TR - Turchia 245
HK - Hong Kong 217
FI - Finlandia 193
IE - Irlanda 193
GB - Regno Unito 182
BR - Brasile 143
DE - Germania 125
FR - Francia 101
RU - Federazione Russa 87
NG - Nigeria 68
IN - India 50
CA - Canada 47
BD - Bangladesh 39
BE - Belgio 21
JP - Giappone 17
MX - Messico 12
NL - Olanda 9
AR - Argentina 8
AT - Austria 8
ES - Italia 8
MY - Malesia 7
EU - Europa 6
IQ - Iraq 6
MD - Moldavia 6
ID - Indonesia 5
PL - Polonia 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BG - Bulgaria 4
CL - Cile 4
EC - Ecuador 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AU - Australia 3
CO - Colombia 3
CR - Costa Rica 3
EE - Estonia 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
SV - El Salvador 3
TH - Thailandia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
DK - Danimarca 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
PR - Porto Rico 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
GL - Groenlandia 1
GR - Grecia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
UZ - Uzbekistan 1
Totale 12.893
Salva come PNG Salva come JPEG
Città #
Milan 1.305
Fairfield 796
Chandler 587
Jacksonville 463
Ashburn 447
San Jose 443
Woodbridge 442
Seattle 375
Singapore 356
Houston 330
Wilmington 305
Ann Arbor 253
Cambridge 250
Council Bluffs 227
Hong Kong 215
Dublin 192
Dallas 174
Chicago 166
Princeton 154
Izmir 145
Nyköping 144
Boardman 104
The Dalles 92
Dong Ket 88
San Mateo 77
Rome 75
Como 70
Abuja 68
Lauterbourg 68
Beijing 63
Dearborn 60
Hanoi 45
San Diego 44
Ho Chi Minh City 42
Los Angeles 42
New York 35
Santa Clara 35
Ogden 33
Philadelphia 32
Helsinki 27
Norwalk 21
Brussels 19
Düsseldorf 18
Pune 17
São Paulo 17
Munich 14
Tokyo 14
Edinburgh 13
Atlanta 12
London 12
Turku 12
Orem 11
Verona 11
Brooklyn 10
Toronto 10
Kunming 9
Brasília 8
Las Vegas 8
Miami 8
Nanjing 8
San Francisco 8
Hefei 7
Mexico City 7
Montreal 7
Nanchang 7
Amsterdam 6
Auburn Hills 6
Buffalo 6
Chennai 6
Frankfurt am Main 6
Guangzhou 6
Stockholm 6
Catania 5
Columbus 5
Dhaka 5
Kuala Lumpur 5
Louisville 5
New Delhi 5
Rio de Janeiro 5
Bari 4
Bologna 4
Boston 4
Chengdu 4
Chongqing 4
Fort Worth 4
Fuzhou 4
Jinan 4
Johannesburg 4
Milton Keynes 4
Nuremberg 4
Phoenix 4
Redmond 4
Shanghai 4
Tianjin 4
Washington 4
Belo Horizonte 3
Bolzano 3
Charlotte 3
Curitiba 3
Da Nang 3
Totale 9.313
Salva come PNG Salva come JPEG
Nome #
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 254
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease 251
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms 229
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. 209
Changes of neuroendocrine axes in patients with menstrual migraine. 199
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE. 196
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. 195
Disordered pupil reactivity in Parkinson's disease. 194
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents. 191
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. 190
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age. 190
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. 189
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. 189
The association of menstrual migraine with the premenstrual syndrome. 189
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. 188
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin. 187
Combined response of plasma and platelet catecholamines to different types of short-term stress. 187
The brain as a target for adrenocortical steroids: cognitive implications. 186
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 184
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. 180
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias. 180
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection. 178
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale. 177
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. 177
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 177
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. 177
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. 176
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. 176
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. 176
Functional changes of the basal ganglia circuitry in Parkinson's disease. 175
Platelet catecholamines in cluster headache. 175
Is seborrhea a sign of autonomic impairment in Parkinson's disease? 174
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients. 173
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. 173
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93. 173
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo. 171
The role of language areas in motor control dysfunction in Parkinson's disease. 170
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease. 170
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. 170
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection. 169
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study. 169
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease. 167
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients 167
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus. 166
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. 164
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study. 164
Non-hormonal therapy of premenstrual syndrome. 163
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease 161
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report. 160
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy. 160
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE. 159
Parkinson's disease and reproductive life events. 159
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study. 158
Premenstrual dysphoric disorder and eating disorders. 158
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias. 157
Motor complications of Parkinson's disease. 155
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88. 155
The influence of gender in the evaluation of platelet and plasma catecholamines. 155
Active music therapy and Parkinson's disease: methods. 153
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease. 152
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. 148
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION. 146
Autonomic disorders in Parkinson's disease. 142
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation. 142
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD. 141
The autonomic nervous system and hypoxia: mountain medicine. 140
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS. 139
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease 135
Terguride in stable Parkinson's disease. 131
The effects of physical exercise at high altitude on adrenocortical function in humans. 129
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism. 126
Reproductive life milestones in women with Parkinson's disease. 126
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study. 125
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial. 125
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. 120
COMT inhibition and safety. 117
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid. 110
Totale 12.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022585 0 0 0 112 12 46 28 38 30 116 62 141
2022/20231.405 104 89 219 128 93 302 0 172 165 46 59 28
2023/20241.987 342 358 334 355 361 88 6 69 47 14 2 11
2024/20251.019 2 31 245 31 13 67 11 68 130 61 79 281
2025/20262.209 123 100 111 218 287 100 579 71 272 124 103 121
2026/2027648 45 167 404 32 0 0 0 0 0 0 0 0
Totale 12.908